|
 |
|
|
Clinical Update:
|
Marvin B. Frager DMD
Graduate of Tufts School of Dental Medicine
This was a special symposium that Dr. Marvin B. Frager was invited to as a guest. Included in this symposium were committees from Harvard Institute of Medicine, Mayo Clinic, Albert Einstein College of Medicine, Michigan Head, Pain and Neurogical Institute and several other centers.
Please note excerpts on the invitation from this symposium in the next two paragraphs.
1) Migraine is a chronic neurological disease. Although the treatment of Migraine include a combination of nonpharmacologic and pharmacoligic techniques, patients with chronic migraine should be treated primarily with preventive medicine.
2) Many of these medications, however, cause significant adverse side effects. Additionally, there is a lack of evidence to support the effectiveness of these treatments, since most preventive agents used for chronic migraine have not been examined in well-designed double blind studies. Consequently, the management of migraine symptoms is challenging for clinicians, and (other significant, clinically proven) preventive treatments may fill an important therapeutic need.
SUMMARY OF PARAGRAPHS 2 AND 3: These famous groups admit to their inadequacy and limited success in treating Migraine patients. However they do openly admit that other significant, clinically proven ways of treating Migraine patients may fill an important therapeutic need. After you examine this web site you will clearly see that I am already providing a significant, clinically proven natural therapy and treatment.
|
|
|
|
|
